CAR-T bunková terapia na Slovensku // SOLEN

Onkológia 6/2025

CAR-T cell therapy in Slovakia

CAR-T cell therapy represents a breakthrough method in the treatment of hematological diseases, a symbol of personalized medicine and hope for patients who no longer benefit from standard therapies. Currently, 3 products are available in Slovakia for the treatment of B-cell non-Hodgkin lymphomas (B-NHL) and B-acute lymphoblastic leukemia (B-ALL). In the near future, we expect spectrum expansion including multiple myeloma (MM) and follicular lymphoma (FL).

Keywords: CAR-T therapy, immunotherapy, B-acute lymphoblastic leukemia, B-cell non-Hodgkin lymphomas, diffuse large B-cell lymphoma